164 related articles for article (PubMed ID: 33522705)
21. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
Mosquera C; Koutlas NJ; Fitzgerald TL
Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
[TBL] [Abstract][Full Text] [Related]
22. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).
González-Flores E; Serrano R; Sevilla I; Viúdez A; Barriuso J; Benavent M; Capdevila J; Jimenez-Fonseca P; López C; Garcia-Carbonero R
Clin Transl Oncol; 2019 Jan; 21(1):55-63. PubMed ID: 30535553
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine gastro-enteropancreatic tumors - from eminence based to evidence-based medicine - A Scandinavian view.
Öberg K
Scand J Gastroenterol; 2015 Jun; 50(6):727-39. PubMed ID: 25855088
[TBL] [Abstract][Full Text] [Related]
24. Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.
Shin Y; Ha SY; Hyeon J; Lee B; Lee J; Jang KT; Kim KM; Park YS; Park CK
Cancer Res Treat; 2015 Oct; 47(4):738-46. PubMed ID: 25687852
[TBL] [Abstract][Full Text] [Related]
25. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
Ptasnuka M; Ozolins A; Narbuts Z; Truskovs A; Sperga M; Plaudis H
World J Surg; 2020 Feb; 44(2):585-593. PubMed ID: 31605174
[TBL] [Abstract][Full Text] [Related]
26. Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources.
Darbà J; Marsà A
BMC Cancer; 2019 Dec; 19(1):1226. PubMed ID: 31842791
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors.
Kamp K; Alwani RA; Korpershoek E; Franssen GJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2016 Mar; 174(3):271-80. PubMed ID: 26643855
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine tumors in children and young adults: rare or not so rare.
Sarvida ME; O'Dorisio MS
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):65-80, vii. PubMed ID: 21349411
[TBL] [Abstract][Full Text] [Related]
29. Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver.
Keutgen XM; Schadde E; Pommier RF; Halfdanarson TR; Howe JR; Kebebew E
Semin Oncol; 2018 Aug; 45(4):232-235. PubMed ID: 30318110
[TBL] [Abstract][Full Text] [Related]
30. Multidisciplinary approach for the treatment of neuroendocrine tumors.
de Herder WW; Mazzaferro V; Tavecchio L; Wiedenmann B
Tumori; 2010; 96(5):833-46. PubMed ID: 21302641
[No Abstract] [Full Text] [Related]
31. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).
Phan AT; Oberg K; Choi J; Harrison LH; Hassan MM; Strosberg JR; Krenning EP; Kocha W; Woltering EA; Maples WJ;
Pancreas; 2010 Aug; 39(6):784-98. PubMed ID: 20664476
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic tumors in children and adolescents: the Italian TREP project experience.
Dall'igna P; Cecchetto G; Bisogno G; Conte M; Chiesa PL; D'Angelo P; De Leonardis F; De Salvo G; Favini F; Ferrari A;
Pediatr Blood Cancer; 2010 May; 54(5):675-80. PubMed ID: 19998473
[TBL] [Abstract][Full Text] [Related]
33. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic neuroendocrine tumors: a review.
Young K; Iyer R; Morganstein D; Chau I; Cunningham D; Starling N
Future Oncol; 2015; 11(5):853-64. PubMed ID: 25757686
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine gastrointestinal tumors--a condensed overview of diagnosis and treatment.
Oberg K
Ann Oncol; 1999; 10 Suppl 2():S3-8. PubMed ID: 10399026
[TBL] [Abstract][Full Text] [Related]
36. Evaluation and Management of Neuroendocrine Tumors of the Pancreas.
Scott AT; Howe JR
Surg Clin North Am; 2019 Aug; 99(4):793-814. PubMed ID: 31255207
[TBL] [Abstract][Full Text] [Related]
37. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
38. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
[TBL] [Abstract][Full Text] [Related]
39. Hegemony and cost-effectiveness of endoscopic ultrasound (EUS) in the field of gastroenteropancreatic-neuroendocrine tumors (GEP-NETs).
De Angelis C; Manfrè SF; Bruno M; Pellicano R
Minerva Med; 2014 Oct; 105(5):363-70. PubMed ID: 25325565
[TBL] [Abstract][Full Text] [Related]
40. Trends in diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in India: A report of multicenter data from a web-based registry.
Palepu J; Shrikhande SV; Bhaduri D; Shah RC; Sirohi B; Chhabra V; Dhar P; Sastry R; Sikora S
Indian J Gastroenterol; 2017 Nov; 36(6):445-451. PubMed ID: 29457213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]